FDA advisory panel endorses Johnson & Johnson Covid-19 vaccine

An advisory panel on Friday recommended the Food and Drug Administration grant an emergency use authorization for Johnson & Johnson’s Covid-19 vaccine developed by Johnson & Johnson, which would become the third vaccine authorized in the United States and the first to require a single shot.

In a statement issued shortly after the vote, the FDA said it has told the company regulators “will rapidly work toward finalization and issuance of an emergency use authorization.” The agency also said it has notified federal partners involved in vaccine distribution “so they can execute their plans for timely vaccine distribution.”

Read the rest…

FDA advisory panel endorses Johnson & Johnson Covid-19 vaccine

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top